In contrast, transcript levels of both MTF2 and MDM2 are elevated in diffuse large B-cell lymphoma and esophageal carcinoma, whereas both MTF2 and MDM2 transcripts are down-regulated in malignant ovarian cancer (serous cystadenocarcinoma). Here, MDM2 is linked to serous cystadenocarcinoma.